Fischer, P B <br/><br/>
N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.  [electronic resource] 

 -  Journal of virology  Oct 1996 
 - 7143-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-538X 
<br/><br/><label>Standard No.: </label>10.1128/JVI.70.10.7143-7152.1996  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Deoxynojirimycin--analogs & derivatives<br/>Animals<br/>Antiviral Agents--pharmacology<br/>CHO Cells<br/>Cricetinae<br/>Epitopes--immunology<br/>HIV Antibodies--immunology<br/>HIV Envelope Protein gp120--immunology<br/>HIV Infections<br/>HIV-1--drug effects<br/>Humans<br/>Protein Conformation<br/>Virus Replication--drug effects